Endologix, Inc. (ELGX) Posts Q1 Loss of 7c/Share; Reaffirms Outlook
Tweet
Share
E-mailGet Alerts ELGX Hot Sheet
Price: $0.22 --0%
Financial Fact:
Research and development: 8.24M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Research and development: 8.24M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Endologix, Inc. (NASDAQ: ELGX) reported Q1 EPS of ($0.07), $0.01 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $24.5 million versus the consensus estimate of $23.29 million.
Endologix, Inc. reaffirmed FY2012 guidance.
For earnings history and earnings-related data on Endologix, Inc. (ELGX) click here.
Endologix, Inc. reaffirmed FY2012 guidance.
For earnings history and earnings-related data on Endologix, Inc. (ELGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- INVO Fertility (IVF) Tops Q2 EPS by 105c
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
